Intelligent Bio Solutions to Participate in the Noble Capital Markets’ 20th Annual Emerging Growth Equity Conference

Rhea-AI Summary

Intelligent Bio Solutions (Nasdaq: INBS), a medical technology company focused on rapid, non-invasive testing solutions, has announced its participation in the Noble Capital Markets' 20th Annual Emerging Growth Equity Conference. The event will take place on December 3-4, 2024, at Florida Atlantic University in Boca Raton, FL.

The company's management team is scheduled to present on Wednesday, December 4, 2024, at 2:00 p.m. ET in Presentation Room 3. A recording of the presentation will be available on INBS's Investor Relations website two days after the event. The management team will also be available for one-on-one meetings with investors during the conference.

NEW YORK, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced that its management team will present at the upcoming Noble Capital Markets’ 20^th Annual Emerging Growth Equity Conference on December 3-4, 2024, in Boca Raton, FL.

Noble Capital Markets’ 20^th Annual Emerging Growth Equity Conference
Dates: December 3-4, 2024
Location: Florida Atlantic University, Boca Raton, FL
Presentation Day and Time: Wednesday, December 4, 2024, at 2:00 p.m. ET  
Presentation Location: Presentation Room 3

A link to the recording of the presentation will be available on INBS’s Investor Relations website two days after the event.

Management will also be available during the event for one-on-one meetings with the investment community. To schedule a meeting, please contact your NobleCon representative or KCSA Strategic Communications by emailing INBS@kcsa.com.

About Intelligent Bio Solutions Inc.
Intelligent Bio Solutions Inc. (NASDAQ: INBS) is a medical technology company delivering innovative, rapid, non-invasive testing solutions. The Company believes that its Intelligent Fingerprinting Drug Screening System will revolutionize portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields. Designed as a hygienic and cost-effective system, the test screens for the recent use of drugs commonly found in the workplace, including opiates, cocaine, methamphetamine, and cannabis. With sample collection in seconds and results in under ten minutes, this technology would be a valuable tool for employers in safety-critical industries. The Company’s current customer segments outside the US include construction, manufacturing and engineering, transport and logistics firms, drug treatment organizations, and coroners.

For more information, visit: http://www.ibs.inc/

Company Contact:  
Intelligent Bio Solutions Inc.  
info@ibs.inc  

Investor & Media Contact:   
Valter Pinto, Managing Director   
KCSA Strategic Communications   
PH: (212) 896-1254   
INBS@kcsa.com

FAQ

When is Intelligent Bio Solutions (INBS) presenting at the Noble Capital Markets Conference?

Intelligent Bio Solutions (INBS) is presenting on Wednesday, December 4, 2024, at 2:00 p.m. ET in Presentation Room 3 at the Noble Capital Markets Conference.

Where can investors watch INBS's Noble Conference presentation recording?

The recording of INBS's presentation will be available on the company's Investor Relations website two days after the event.

How can investors schedule one-on-one meetings with INBS management at the Noble Conference?

Investors can schedule meetings by contacting their NobleCon representative or by emailing INBS@kcsa.com through KCSA Strategic Communications.

Where is the Noble Capital Markets Conference featuring INBS being held?

The conference is being held at Florida Atlantic University in Boca Raton, FL, on December 3-4, 2024.